Literature DB >> 23061881

Therapeutic option of plasmid-DNA based gene transfer.

Yoshiaki Taniyama1, Junya Azuma, Yasuo Kunugiza, Kazuma Iekushi, Hiromi Rakugi, Ryuichi Morishita.   

Abstract

Gene therapy offers a novel approach for the prevention and treatment of a variety of diseases, but it is not yet a common method in clinical cases because of various problems. Viral vectors show high efficiency of gene transfer, but they have some problems with toxicity and immunity. On the other hand, plasmid deoxyribonucleic acid (DNA)-based gene transfer is very safe, but its efficiency is relatively low. Especially, plasmid DNA gene therapy is used for cardiovascular disease because plasmid DNA transfer is possible for cardiac or skeletal muscle. Clinical angiogenic gene therapy using plasmid DNA gene transfer has been attempted in patients with peripheral artery disease, but a phase III clinical trial did not show sufficient efficiency. In this situation, more efficient plasmid DNA gene transfer is needed all over the world. This review focuses on plasmid DNA gene transfer and its enhancement, including ultrasound with microbubbles, electroporation, hydrodynamic method, gene gun, jet injection, cationic lipids and cationic polymers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061881     DOI: 10.2174/156802612803531342

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  8 in total

1.  Ultrasound-targeted cationic microbubble-mediated gene transfection and inhibition of retinal neovascularization.

Authors:  Ming-Xing Wu; Yu Zhou; Xi-Yuan Zhou; Yan Xu
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

2.  Small Circular DNAs in Human Pathology.

Authors:  Stephany Carolina Barreto; Madhuri Uppalapati; Amitabha Ray
Journal:  Malays J Med Sci       Date:  2014-05

Review 3.  Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.

Authors:  Kenneth R Chien; Lior Zangi; Kathy O Lui
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

4.  Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion.

Authors:  Fang-Fang Liu; Chao-Ying Liu; Xiao-Ping Li; Sheng-Zhe Zheng; Qing-Quan Li; Qun Liu; Lei Song
Journal:  Neural Regen Res       Date:  2015-03       Impact factor: 5.135

5.  Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles.

Authors:  Yu Zhou; Haitao Gu; Yan Xu; Fan Li; Shaojing Kuang; Zhigang Wang; Xiyuan Zhou; Huafeng Ma; Pan Li; Yuanyi Zheng; Haitao Ran; Jia Jian; Yajing Zhao; Weixiang Song; Qiushi Wang; Dong Wang
Journal:  Theranostics       Date:  2015-02-01       Impact factor: 11.556

Review 6.  Translational Advances of Hydrofection by Hydrodynamic Injection.

Authors:  Luis Sendra; María José Herrero; Salvador F Aliño
Journal:  Genes (Basel)       Date:  2018-03-01       Impact factor: 4.096

7.  The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system.

Authors:  Keisuke Maruyama; Naoki Nakagawa; Tatsuya Aonuma; Yukihiro Saito; Taiki Hayasaka; Kohei Kano; Kiwamu Horiuchi; Naofumi Takehara; Jun-Ichi Kawabe; Naoyuki Hasebe
Journal:  Sci Rep       Date:  2019-05-24       Impact factor: 4.379

8.  Experimental endostatin-GFP gene transfection into human retinal vascular endothelial cells using ultrasound-targeted cationic microbubble destruction.

Authors:  Yan Xu; Zongyuan Xie; Yu Zhou; Xiyuan Zhou; Pan Li; Zhigang Wang; Qunxia Zhang
Journal:  Mol Vis       Date:  2015-08-25       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.